Aurinia Pharmaceuticals to Present at Two Upcoming Virtual Healthcare Conferences

Rhea-AI Summary

Aurinia Pharmaceuticals (NASDAQ: AUPH) announced that its management will participate in upcoming virtual investor conferences. Key events include an on-demand fireside chat at the H.C. Wainwright Virtual BioConnect 2021 Conference starting January 11, 2021, at 6:00 a.m. EST, and a panel discussion led by Dr. Scott Gottlieb at 12:00 p.m. EST on the same day. Additionally, a fireside chat at the J.P. Morgan 39th Annual Healthcare Conference is scheduled for January 14, 2021, at 4:30 p.m. EST. Interested parties can access the webcasts on Aurinia's corporate website.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the management team will participate in two upcoming virtual investor conferences and participate in a panel discussion hosted by Dr. Scott Gottlieb, former FDA Commissioner:

• H.C. Wainwright Virtual BioConnect 2021 Conference. On-demand fireside chat available beginning Monday, January 11, 2021 at 6:00 a.m. EST;
• Scott Gottlieb, M.D. Hosts a Panel Discussion on Clinical Trials with Neil Solomons, M.D., Chief Medical Officer of Aurinia, during the H.C. Wainwright BioConnect 2021 Conference on Monday, January 11, 2021 at 12:00 p.m. EST; and
• J.P Morgan 39^th Annual Healthcare Conference. Fireside chat to be hosted on Thursday, January 14, 2021 at 4:30 p.m. EST.

In order to listen to the audio webcast, interested parties can register and access the live webcast under “News/Events” through the “Investors” section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcast will be available for 30 days on Aurinia’s website.

ABOUT AURINIA

Aurinia Pharmaceuticals is a late-stage clinical biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company is currently seeking FDA approval of voclosporin for the potential treatment of lupus nephritis (LN). The Company’s head office is in Victoria, British Columbia and its U.S. commercial hub is in Rockville, Maryland. The Company focuses its development efforts globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210108005055/en/

FAQ

What conferences will Aurinia Pharmaceuticals participate in January 2021?

Aurinia Pharmaceuticals will participate in the H.C. Wainwright Virtual BioConnect 2021 Conference and the J.P. Morgan 39th Annual Healthcare Conference.

When is the H.C. Wainwright Virtual BioConnect 2021 Conference?

The H.C. Wainwright Virtual BioConnect Conference will begin on January 11, 2021, with an on-demand fireside chat available at 6:00 a.m. EST.

What time is the panel discussion hosted by Dr. Scott Gottlieb?

The panel discussion hosted by Dr. Scott Gottlieb will take place on January 11, 2021, at 12:00 p.m. EST.

When will the J.P. Morgan 39th Annual Healthcare Conference occur?

The J.P. Morgan 39th Annual Healthcare Conference will be held on January 14, 2021, at 4:30 p.m. EST.

How can I access the webcasts of Aurinia's conference presentations?

The webcasts can be accessed through the 'News/Events' section on Aurinia's corporate website.